Journal article
Increased cortical neuronal responses to NMDA and improved attentional set-shifting performance in rats following prebiotic (B-GOS®) ingestion
- Abstract:
- We have previously shown that prebiotics (dietary fibres that augment the growth of indigenous beneficial gut bacteria) such as BimunoTM galacto-oligosaccharides (B-GOS®), increased N-methyl-D-aspartate (NMDA) receptor levels in the rat brain. The current investigation examined the functional correlates of these changes in B-GOS®-fed rats by measuring cortical neuronal responses to NMDA using in vivo NMDA micro-iontophoresis electrophysiology, and performance in the attentional set-shifting task. Adult male rats were supplemented with B-GOS® in the drinking water 3 weeks prior to in vivo iontophoresis or behavioural testing. Cortical neuronal responses to NMDA iontophoresis, were greater (+30%) in B-GOS® administered rats compared to non-supplemented controls. The intake of B-GOS® also partially hindered the reduction of NMDA responses by the glycine site antagonist, HA-966. In the attentional set-shifting task, B-GOS® -fed rats shifted from an intra-dimensional to an extra-dimensional set in fewer trials than controls, thereby indicating greater cognitive flexibility. An initial exploration into the mechanisms revealed that rats ingesting B-GOS® had increased levels of plasma acetate, and cortical GluN2B subunits and Acetyl Co-A Carboxylase mRNA. These changes were also observed in rats fed daily for 3 weeks with glyceryl triacetate, though unlike B-GOS®, cortical histone deacetylase (HDAC1, HDAC2) mRNAs were also increased which suggested an additional epigenetic action of direct acetate supplementation. Our data demonstrate that a pro-cognitive effect of B-GOS® intake in rats is associated with an increase in cortical NMDA receptor function, but the role of circulating acetate derived from gut bacterial fermentation of this prebiotic requires further investigation.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.1MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.euroneuro.2017.11.001
Authors
+ Biotechnology and Biological Sciences Research Council
More from this funder
- Grant:
- Industrial Partnership Award (Principal Investigator, Dr Burnet
- Grant Code: BB/I006311/1
- Publisher:
- Elsevier
- Journal:
- European Neuropsychopharmacology More from this journal
- Volume:
- 28
- Issue:
- 1
- Pages:
- 211-224
- Publication date:
- 2017-11-22
- Acceptance date:
- 2017-11-02
- DOI:
- ISSN:
-
0924-977X
- Keywords:
- Pubs id:
-
pubs:742558
- UUID:
-
uuid:3e4df25b-1aa4-4c33-acb7-e5f8279b2b50
- Local pid:
-
pubs:742558
- Source identifiers:
-
742558
- Deposit date:
-
2017-11-03
- ARK identifier:
Terms of use
- Copyright holder:
- Gronier et al
- Copyright date:
- 2017
- Notes:
- Copyright © 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record